Deuterated 2-amino-3-hydroxypropanoic acid derivatives

US9108902B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9108902-B2
Application numberUS-201414220770-A
CountryUS
Kind codeB2
Filing dateMar 20, 2014
Priority dateSep 16, 2008
Publication dateAug 18, 2015
Grant dateAug 18, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This invention relates to novel 2-amino-3-hydroxypropanoic acid derivatives and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering an NMDA glycine-site antagonist.

First claim

Opening claim text (preview).

I claim: 1. A compound of formula I: or a pharmaceutically acceptable salt thereof, wherein: Y 1 is CD 3 ; Y 2 is CD 3 ; each Z variable is independently selected from hydrogen and deuterium; each R variable is independently selected from hydrogen and deuterium; and any atom not designated as deuterium is present at its natura…

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Next steps

Free tools are coming soon. Tell us what you want to track and we'll notify you.

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9108902B2 cover?
This invention relates to novel 2-amino-3-hydroxypropanoic acid derivatives and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering an NMDA glycine-site antagonist.
Who is the assignee on this patent?
Concert Pharmaceuticals Inc
What technology area does this patent fall under?
Primary CPC classification C07C235/34. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).